Shamburg News · 8-K filed Oct 5, 2026, 4:20 PM EDT
SeaStar Medical Announces Warrant Exercise for Approximately $3.3 Million Gross Proceeds
ICU · SeaStar Medical Holding Corp
- Material agreement
- Financing
- Materiality: medium
On October 2, 2026, SeaStar Medical Holding Corporation entered into letter agreements with holders of prior warrants to purchase 854,002 shares of common stock, who exercised them for cash at a reduced exercise price of $3.866 per share. The company received approximately $3.3 million in gross proceeds before placement agent fees and offering expenses, with the offering closing on October 5, 2026. Holders also received new unregistered Series A and Series B warrants exercisable at $3.616 per share, and the company agreed to file a resale registration statement.
Source: SEC EDGAR, Form 8-K, Items 1.01, 3.02, 8.01, 9.01, accession 0001437749-26-032035.
Written from the filing by Shamburg Markets. Figures are as reported by the company.